Axess Shows Promise for Living HD Grafts

A synthetic, biocompatible blood vessel becomes colonized by a patient's own tissue. Now tested in 11 patients for more than 600 treatments, the new graft material is safe and works well—with no aneurysms or infections to date.

Read the full article » | Posted 05-12-2022

Related Articles

• Xeltis is Trialing its Polymer-based Vascular Access Posted 03-12-2026
• New Bluetooth-enabled CAPD System Enhanced Patient Satisfaction Posted 03-12-2026
• Emerging Biomarker Research in PD Posted 03-12-2026
• Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026